Bioequivalence Study Between Temozolomide Oral Suspension (Ped-TMZ) and Temodal® Capsules
Status:
Recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
Primary objective:
• Evaluate bioequivalence between Temozolomide Oral Suspension and Temodal® capsules for oral
administration.
Secondary objectives:
- Define the pharmacokinetic parameters of Temozolomide Oral Suspension.
- Assess the buccal safety of Temozolomide Oral Suspension.